Dong, E., Du, H. & Gardner, L. An interactive web-based dashboard to track COVID-19 in real time. Lancet Infect. Dis. 20, 533–534 (2020).

Article  CAS  Google Scholar 

Wichmann, D. et al. Autopsy findings and venous thromboembolism in patients with COVID-19: a prospective cohort study. Ann. Intern. Med. 173, 268–277 (2020).

Article  Google Scholar 

Klok, F. A. et al. Confirmation of the high cumulative incidence of thrombotic complications in critically ill ICU patients with COVID-19: An updated analysis. Thromb. Res. 191, 148–150 (2020).

Article  CAS  Google Scholar 

Xie, Y., Xu, E., Bowe, B. & Al-Aly, Z. Long-term cardiovascular outcomes of COVID-19. Nat. Med. 28, 583–590 (2022).

Article  CAS  Google Scholar 

Virani, S. S. et al. Heart disease and stroke statistics—2021 update. Circulation 143, e254–e743 (2021).

Article  Google Scholar 

Wilcox, T., Smilowitz, N. & Berger, J. Age and sex differences in incident thrombosis in patients hospitalized with COVID-19. J. Am. Coll. Cardiol. 77, 1826 (2021).

Article  CAS  Google Scholar 

Chen, A.-T., Wang, C.-Y., Zhu, W.-L. & Chen, W. Coagulation disorders and thrombosis in COVID-19 patients and a possible mechanism involving endothelial cells: a review. Aging Dis. 13, 144–156 (2022).

Article  Google Scholar 

Behzadifard, M. & Soleimani, M. NETosis and SARS-COV-2 infection related thrombosis: a narrative review. Thromb. J. 20, 13 (2022).

Article  CAS  Google Scholar 

Campello, E. et al. Thrombin generation in patients with COVID-19 with and without thromboprophylaxis. Clin. Chem. Lab. Med. 59, 1323–1330 (2021).

Article  CAS  Google Scholar 

Skendros, P. et al. Complement and tissue factor–enriched neutrophil extracellular traps are key drivers in COVID-19 immunothrombosis. J. Clin. Investig. 130, 6151–6157 (2020).

Article  CAS  Google Scholar 

Goshua, G. et al. Endotheliopathy in COVID-19-associated coagulopathy: evidence from a single-centre, cross-sectional study. Lancet Haematol. 7, e575–e582 (2020).

Article  Google Scholar 

Thachil, J. et al. ISTH interim guidance on recognition and management of coagulopathy in COVID-19. J. Thromb. Haemost. 18, 1023–1026 (2020).

Article  CAS  Google Scholar 

Sholzberg, M. et al. Effectiveness of therapeutic heparin versus prophylactic heparin on death, mechanical ventilation, or intensive care unit admission in moderately ill patients with COVID-19 admitted to hospital: RAPID randomised clinical trial. Brit. Med. J. 375, n2400 (2021).

Article  Google Scholar 

The REMAP-CAP, ACTIV-4a & ATTACC Investigators Therapeutic anticoagulation with heparin in critically ill patients with COVID-19. N. Engl. J. Med. 385, 777–789 (2021)..

Kalogeris, T., Baines, C. P., Krenz, M. & Korthuis, R. J. Cell biology of ischemia/reperfusion injury. Int. Rev. Cell Mol. Biol. 298, 229–317 (2012).

Article  CAS  Google Scholar 

Blanc, R. et al. Recent advances in devices for mechanical thrombectomy. Expert Rev. Med. Devices 17, 697–706 (2020).

Article  CAS  Google Scholar 

Whyte, C. S., Morrow, G. B., Mitchell, J. L., Chowdary, P. & Mutch, N. J. Fibrinolytic abnormalities in acute respiratory distress syndrome (ARDS) and versatility of thrombolytic drugs to treat COVID-19. J. Thromb. Haemost. 18, 1548–1555 (2020).

Article  CAS  Google Scholar 

Ucar, E. Y. Update on thrombolytic therapy in acute pulmonary thromboembolism. Eurasian J. Med. 51, 186–190 (2019).

CAS  Google Scholar 

Warach, S. J., Dula, A. N. & Milling, T. J. Tenecteplase thrombolysis for acute ischemic stroke. Stroke 51, 3440–3451 (2020).

Article  Google Scholar 

Wang, J. et al. Tissue plasminogen activator (tPA) treatment for COVID-19 associated acute respiratory distress syndrome (ARDS): a case series. J. Thromb. Haemost. 18, 1752–1755 (2020).

Article  CAS  Google Scholar 

Kosanovic, D. et al. Recombinant tissue plasminogen activator treatment for COVID-19 associated ARDS and acute cor pulmonale. Int. J. Infect. Dis. 104, 108–110 (2021).

Article  CAS  Google Scholar 

Barrett, C. D. et al. Study of alteplase for respiratory failure in SARS-CoV-2 COVID-19: a vanguard multicenter, rapidly adaptive, pragmatic, randomized controlled trial. Chest 161, 710–727 (2022).

Article  CAS  Google Scholar 

Rothschild, D. P., Goldstein, J. A. & Bowers, T. R. Low-dose systemic thrombolytic therapy for treatment of submassive pulmonary embolism: clinical efficacy but attendant hemorrhagic risks. Catheter. Cardiovasc. Interv. 93, 506–510 (2019).

Google Scholar 

Huang, X. et al. Nanotechnology-based strategies against SARS-CoV-2 variants. Nat. Nanotechnol. 17, 1027–1037 (2022).

Article  CAS  Google Scholar 

Colasuonno, M. et al. Erythrocyte-inspired discoidal polymeric nanoconstructs carrying tissue plasminogen activator for the enhanced lysis of blood clots. ACS Nano 12, 12224–12237 (2018).

Article  CAS  Google Scholar 

Xu, J. et al. Sequentially site-specific delivery of thrombolytics and neuroprotectant for enhanced treatment of ischemic stroke. ACS Nano 13, 8577–8588 (2019).

Article  CAS  Google Scholar 

Xu, J. et al. Engineered nanoplatelets for targeted delivery of plasminogen activators to reverse thrombus in multiple mouse thrombosis models. Adv. Mater. 32, 1905145 (2020).

Article  CAS  Google Scholar 

Russell, L. M., Hultz, M. & Searson, P. C. Leakage kinetics of the liposomal chemotherapeutic agent doxil: the role of dissolution, protonation, and passive transport, and implications for mechanism of action. J. Control. Release 269, 171–176 (2018).

Article  CAS  Google Scholar 

Kim, J.-Y., Kim, J.-K., Park, J.-S., Byun, Y. & Kim, C.-K. The use of PEGylated liposomes to prolong circulation lifetimes of tissue plasminogen activator. Biomaterials 30, 5751–5756 (2009).

Article  CAS  Google Scholar 

Zhang, W., Mehta, A., Tong, Z., Esser, L. & Voelcker, N. H. Development of polymeric nanoparticles for blood–brain barrier transfer—strategies and challenges. Adv. Sci. 8, 2003937 (2021).

Article  CAS  Google Scholar 

Matoori, S. & Leroux, J.-C. Twenty-five years of polymersomes: lost in translation? Mater. Horiz. 7, 1297–1309 (2020).

Article  CAS  Google Scholar 

Wang, X. et al. Near-infrared triggered release of uPA from nanospheres for localized hyperthermia-enhanced thrombolysis. Adv. Funct. Mater. 27, 1701824 (2017).

Article  Google Scholar 

Wang, S. et al. Accelerating thrombolysis using a precision and clot-penetrating drug delivery strategy by nanoparticle-shelled microbubbles. Sci. Adv. 6, eaaz8204 (2020).

Article  CAS  Google Scholar 

Voros, E. et al. TPA immobilization on iron oxide nanocubes and localized magnetic hyperthermia accelerate blood clot lysis. Adv. Funct. Mater. 25, 1709–1718 (2015).

Article  CAS  Google Scholar 

Yang, G., Phua, S. Z. F., Bindra, A. K. & Zhao, Y. Degradability and clearance of inorganic nanoparticles for biomedical applications. Adv. Mater. 31, 1805730 (2019).

Article  Google Scholar 

Chen, K. et al. Intrinsic biotaxi solution based on blood cell membrane cloaking enables fullerenol thrombolysis in vivo. ACS Appl. Mater. Interfaces 12, 14958–14970 (2020).

Article  CAS  Google Scholar 

Wang, J., Chen, D. & Ho, E. A. Challenges in the development and establishment of exosome-based drug delivery systems. J. Control. Release 329, 894–906 (2021).

Article  CAS  Google Scholar 

Kang, H., Seo, J., Yang, E.-J. & Choi, I.-H. Silver nanoparticles induce neutrophil extracellular traps via activation of PAD and neutrophil elastase. Biomolecules 11, 317 (2021).

Article  CAS  Google Scholar 

Yang, Y. et al. Gold nanoparticles synergize with bacterial lipopolysaccharide to enhance class A scavenger receptor dependent particle uptake in neutrophils and augment neutrophil extracellular traps formation. Ecotoxicol. Environ. Saf. 211, 111900 (2021).

Article  CAS  Google Scholar 

Bartneck, M., Keul, H. A., Zwadlo-Klarwasser, G. & Groll, J. Phagocytosis independent extracellular nanoparticle clearance by human immune cells. Nano Lett. 10, 59–63 (2010).

Article  CAS  Google Scholar 

Snoderly, H. T. et al. PEGylation of metal oxide nanoparticles modulates neutrophil extracellular trap formation. Biosensors 12, 123 (2022).

Article  CAS  Google Scholar 

Bilyy, R. et al. Inert coats of magnetic nanoparticles prevent formation of occlusive intravascular co-aggregates with neutrophil extracellular traps. Front. Immunol. 9, 2266 (2018).

Article  Google Scholar 

Mukherjee, S. P. et al. Graphene oxide is degraded by neutrophils and the degradation products are non-genotoxic. Nanoscale 10, 1180–1188 (2018).

Article  CAS  Google Scholar 

Hwang, T.-L., Aljuffali, I. A., Hung, C.-F., Chen, C.-H. & Fang, J.-Y. The impact of cationic solid lipid nanoparticles on human neutrophil activation and formation of neutrophil extracellular traps (NETs). Chem. Biol. Interact. 235, 106–114 (2015).

Article  CAS  Google Scholar 

Muñoz, L. E. et al. Nanoparticles size-dependently initiate self-limiting NETosis-driven inflammation. Proc. Natl Acad. Sci. USA 113, E5856–E5865 (2016).

Article  Google Scholar 

Yang, H. et al. Nanomaterial exposure induced neutrophil extracellular traps: a new target in inflammation and innate immunity. J. Immunol. Res. 2019, 3560180 (2019).

Article  Google Scholar 

Kutscher, H. L. et al. Threshold size for optimal passive pulmonary targeting and retention of rigid microparticles in rats. J. Control. Release 143, 31–37 (2010).

Article  CAS  Google Scholar 

Herda, L. M., Hristov, D. R., Lo Giudice, M. C., Polo, E. & Dawson, K. A. Mapping of molecular structure of the nanoscale surface in bionanoparticles. J. Am. Chem. Soc. 139, 111–114 (2017).

Article  CAS  Google Scholar 

Faria, M. et al. Minimum information reporting in bio-nano experimental literature. Nat. Nanotechnol. 13, 777–785 (2018).

Article  CAS  Google Scholar 

Lu, T.-Y. et al. Dual-targeting glycol chitosan/heparin-decorated polypyrrole nanoparticle for augmented photothermal thrombolytic therapy. ACS Appl. Mater. Interfaces 13, 10287–10300 (2021).

Article  CAS  Google Scholar 

Bachelet, L. et al. Affinity of low molecular weight fucoidan for P-selectin triggers its binding to activated human platelets. Biochim. Biophys. Acta 1790, 141–146 (2009).

Article  CAS  Google Scholar 

Juenet, M. et al. Thrombolytic therapy based on fucoidan-functionalized polymer nanoparticles targeting P-selectin. Biomaterials 156, 204–216 (2018).

Article  CAS  Google Scholar 

Zhang, H. et al. Thrombus-targeted nanoparticles for thrombin-triggered thrombolysis and local inflammatory microenvironment regulation. J. Control. Release 339, 195–207 (2021).

Article  CAS  Google Scholar 

Chang, L.-H. et al. Thrombus-specific theranostic nanocomposite for codelivery of thrombolytic drug, algae-derived anticoagulant and NIR fluorescent contrast agent. Acta Biomater. 134, 686–701 (2021).

Article  CAS  Google Scholar 

Apostolopoulos, V. et al. A global review on short peptides: frontiers and perspectives. Molecules 26, 430 (2021).

Article  CAS  Google Scholar 

Sun, M. et al. Combination targeting of ‘platelets + fibrin’ enhances clot anchorage efficiency of nanoparticles for vascular drug delivery. Nanoscale 12, 21255–21270 (2020).

Article  CAS  Google Scholar 

Pawlowski, C. L. et al. Platelet microparticle-inspired clot-responsive nanomedicine for targeted fibrinolysis. Biomaterials 128, 94–108 (2017).

Article  CAS  Google Scholar 

Yang, A. et al. Thrombin-responsive engineered nanoexcavator with full-thickness infiltration capability for pharmaceutical-free deep venous thrombosis theranostics. Biomater. Sci. 8, 4545–4558 (2020).

Article  CAS  Google Scholar 

Marsh, J. N. et al. A fibrin-specific thrombolytic nanomedicine approach to acute ischemic stroke. Nanomedicine 6, 605–615 (2011).

Article  CAS  Google Scholar 

Schwarz, M. et al. Conformation-specific blockade of the integrin GPIIb/IIIa. Circ. Res. 99, 25–33 (2006).

Article  CAS  Google Scholar 

Bates, A. & Power, C. A. David vs. Goliath: the structure, function, and clinical prospects of antibody fragments. Antibodies 8, 28 (2019).

Article  CAS  Google Scholar 

Yong, K. W., Yuen, D., Chen, M. Z. & Johnston, A. P. R. Engineering the orientation, density, and flexibility of single-domain antibodies on nanoparticles to improve cell targeting. ACS Appl. Mater. Interfaces 12, 5593–5600 (2020).

Article  CAS  Google Scholar 

Lu, R.-M. et al. Development of therapeutic antibodies for the treatment of diseases. J. Biomed. Sci. 27, 1 (2020).

Article  CAS  Google Scholar 

Zhao, Y. et al. Biomimetic fibrin-targeted and H₂O₂-responsive nanocarriers for thrombus therapy. Nano Today 35, 100986 (2020).

Article  CAS  Google Scholar 

Cruz, M. A. et al. Nanomedicine platform for targeting activated neutrophils and neutrophil–platelet complexes using an α1-antitrypsin-derived peptide motif. Nat. Nanotechnol. 17, 1004–1014 (2022).

Article  CAS  Google Scholar 

Korin, N. et al. Shear-activated nanotherapeutics for drug targeting to obstructed blood vessels. Science 337, 738–742 (2012).

Article  CAS  Google Scholar 

Marosfoi, M. G. et al. Shear-activated nanoparticle aggregates combined with temporary endovascular bypass to treat large vessel occlusion. Stroke 46, 3507–3513 (2015).

Article  CAS  Google Scholar 

Wang, Y., Shim, M. S., Levinson, N. S., Sung, H.-W. & Xia, Y. Stimuli-responsive materials for controlled release of theranostic agents. Adv. Funct. Mater. 24, 4206–4220 (2014).

Article  CAS  Google Scholar 

Snider, J. M. et al. Group IIA secreted phospholipase A2 is associated with the pathobiology leading to COVID-19 mortality. J. Clin. Invest. 131, e149236 (2021).

Article  CAS  Google Scholar 

Takahashi, S. et al. Phospholipase A2 expression in coronary thrombus is increased in patients with recurrent cardiac events after acute myocardial infarction. Int. J. Cardiol. 168, 4214–4221 (2013).

Article  Google Scholar 

Gallwitz, M., Enoksson, M., Thorpe, M. & Hellman, L. The extended cleavage specificity of human thrombin. PLoS ONE 7, e31756 (2012).

Article  CAS  Google Scholar 

Freedman, J. E. Oxidative stress and platelets. Arterioscler. Thromb. Vasc. Biol. 28, s11–s16 (2008).

Article  CAS  Google Scholar 

Laforge, M. et al. Tissue damage from neutrophil-induced oxidative stress in COVID-19. Nat. Rev. Immunol. 20, 515–516 (2020).

Article  CAS  Google Scholar 

Mei, T. et al. Encapsulation of tissue plasminogen activator in pH-sensitive self-assembled antioxidant nanoparticles for ischemic stroke treatment—synergistic effect of thrombolysis and antioxidant. Biomaterials 215, 119209 (2019).

Article  CAS  Google Scholar 

Genentech Inc. Efficacy of tocilizumab on patients with COVID-19. ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/study/NCT04356937 (2020).

Simmons, J. Phase 2 trial using rhDNase to reduce mortality in COVID-19 patients with respiratory failure (DAMPENCOVID). ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT04445285 (2020).

Syed, Y. Y. Molnupiravir: first approval. Drugs 82, 455–460 (2022).

Article  CAS  Google Scholar 

Lamb, Y. N. Nirmatrelvir plus ritonavir: first approval. Drugs 82, 585–591 (2022).

Article  CAS  Google Scholar 

Peplow, M. Nanotechnology offers alternative ways to fight COVID-19 pandemic with antivirals. Nat. Biotechnol. 39, 1172–1174 (2021).

Article  CAS  Google Scholar 

He, Q. et al. Antiviral properties of silver nanoparticles against SARS-CoV-2: effects of surface coating and particle size. Nanomaterials 12, 990 (2022).

Article  CAS  Google Scholar 

Jeremiah, S. S., Miyakawa, K., Morita, T., Yamaoka, Y. & Ryo, A. Potent antiviral effect of silver nanoparticles on SARS-CoV-2. Biochem. Biophys. Res. Commun. 533, 195–200 (2020).

Article  CAS  Google Scholar 

Stagi, L. et al. Effective SARS-CoV-2 antiviral activity of hyperbranched polylysine nanopolymers. Nanoscale 13, 16465–16476 (2021).

Article  CAS  Google Scholar 

Zhao, Z. et al. Glycyrrhizic acid nanoparticles as antiviral and anti-inflammatory agents for COVID-19 treatment. ACS Appl. Mater. Interfaces 13, 20995–21006 (2021).

Article  CAS  Google Scholar 

Tan, Q. et al. Macrophage biomimetic nanocarriers for anti-inflammation and targeted antiviral treatment in COVID-19. J. Nanobiotechnol. 19, 173 (2021).

Article  CAS  Google Scholar 

Ma, X. et al. HACE2-exosome-based nano-bait for concurrent SARS-CoV-2 trapping and antioxidant therapy. ACS Appl. Mater. Interfaces 14, 4882–4891 (2022).

Article  CAS  Google Scholar 

Wang, C. et al. Membrane nanoparticles derived from ACE2-rich cells block SARS-CoV-2 infection. ACS Nano 15, 6340–6351 (2021).

Article  CAS  Google Scholar 

Li, Z. et al. Cell-mimicking nanodecoys neutralize SARS-CoV-2 and mitigate lung injury in a non-human primate model of COVID-19. Nat. Nanotechnol. 16, 942–951 (2021).

Article  CAS  Google Scholar 

Peddapalli, A. et al. Demystifying excess immune response in COVID-19 to reposition an orphan drug for down-regulation of NF-κB: a systematic review. Viruses 13, 378 (2021).

Article  CAS  Google Scholar 

Eedara, B. B. et al. Inhalation delivery for the treatment and prevention of COVID-19 infection. Pharmaceutics 13, 1077 (2021).

Article  CAS  Google Scholar 

Miller, M. R. et al. Inhaled nanoparticles accumulate at sites of vascular disease. ACS Nano 11, 4542–4552 (2017).

Article  CAS  Google Scholar 

Lee, Y. Y. et al. Long-acting nanoparticulate DNase-1 for effective suppression of SARS-CoV-2-mediated neutrophil activities and cytokine storm. Biomaterials 267, 120389 (2021).

Article  CAS  Google Scholar 

Park, H. H. et al. Bioinspired DNase-I-coated melanin-like nanospheres for modulation of infection-associated NETosis dysregulation. Adv. Sci. 7, 2001940 (2020).

Article  CAS  Google Scholar 

Alsabani, M. et al. Reduction of NETosis by targeting CXCR1/2 reduces thrombosis, lung injury, and mortality in experimental human and murine sepsis. Br. J. Anaesth. 128, 283–293 (2022).

Article  CAS  Google Scholar 

Beristain-Covarrubias, N. et al. Understanding infection-induced thrombosis: lessons learned from animal models. Front. Immunol. 10, 2569 (2019).

Article  CAS  Google Scholar 

Shou, S. et al. Animal models for COVID-19: hamsters, mouse, ferret, mink, tree shrew, and non-human primates. Front. Microbiol. 12, 626553 (2021).

Article  Google Scholar 

Shi, J. et al. Susceptibility of ferrets, cats, dogs, and other domesticated animals to SARS-coronavirus 2. Science 368, 1016–1020 (2020).

Article  CAS  Google Scholar 

Cicha, I. et al. From design to the clinic: practical guidelines for translating cardiovascular nanomedicine. Cardiovasc. Res. 114, 1714–1727 (2018).

Article  CAS  Google Scholar 

Bai, S. et al. Multimodal and multifunctional nanoparticles with platelet targeting ability and phase transition efficiency for the molecular imaging and thrombolysis of coronary microthrombi. Biomater. Sci. 8, 5047–5060 (2020).

Article  CAS  Google Scholar 

Huang, Y. et al. An activated-platelet-sensitive nanocarrier enables targeted delivery of tissue plasminogen activator for effective thrombolytic therapy. J. Control. Release 300, 1–12 (2019).

Article  CAS  Google Scholar 

Sánchez-Cortés, J. & Mrksich, M. The platelet integrin alphaIIbbeta3 binds to the RGD and AGD motifs in fibrinogen. Chem. Biol. 16, 990–1000 (2009).

Article  Google Scholar 

Absar, S., Nahar, K., Kwon, Y. M. & Ahsan, F. Thrombus-targeted nanocarrier attenuates bleeding complications associated with conventional thrombolytic therapy. Pharm. Res. 30, 1663–1676 (2013).

Article  CAS  Google Scholar 

Zhong, Y. et al. Low-intensity focused ultrasound-responsive phase-transitional nanoparticles for thrombolysis without vascular damage: a synergistic nonpharmaceutical strategy. ACS Nano 13, 3387–3403 (2019).

Article  CAS  Google Scholar 

Chen, H.-A., Ma, Y.-H., Hsu, T.-Y. & Chen, J.-P. Preparation of peptide and recombinant tissue plasminogen activator conjugated poly(lactic-co-glycolic acid) (PLGA) magnetic nanoparticles for dual targeted thrombolytic therapy. Int. J. Mol. Sci. 21, 2690 (2020).

Article  CAS  Google Scholar 

Singh, M. P. et al. Reprogramming the rapid clearance of thrombolytics by nanoparticle encapsulation and anchoring to circulating red blood cells. J. Control. Release 329, 148–161 (2021).

Article  CAS  Google Scholar 

Kawata, H. et al. A new drug delivery system for intravenous coronary thrombolysis with thrombus targeting and stealth activity recoverable by ultrasound. J. Am. Coll. Cardiol. 60, 2550–2557 (2012).

Article  CAS  Google Scholar 

Papayannopoulos, V. Neutrophil extracellular traps in immunity and disease. Nat. Rev. Immunol. 18, 134–147 (2018).

Article  CAS  Google Scholar 

Veras, F. P. et al. SARS-CoV-2–triggered neutrophil extracellular traps mediate COVID-19 pathology. J. Exp. Med. 217, e20201129 (2020).

Article  CAS  Google Scholar 

Arcanjo, A. et al. The emerging role of neutrophil extracellular traps in severe acute respiratory syndrome coronavirus 2 (COVID-19). Sci. Rep. 10, 19630 (2020).

Article  CAS  Google Scholar 

Kaiser, R. et al. Self-sustaining IL-8 loops drive a prothrombotic neutrophil phenotype in severe COVID-19. JCI Insight 6, e150862 (2021).

Article  Google Scholar 

Wu, M. et al. Transcriptional and proteomic insights into the host response in fatal COVID-19 cases. Proc. Natl Acad. Sci. USA 117, 28336–28343 (2020).

Article  CAS  Google Scholar 

Liao, M. et al. Single-cell landscape of bronchoalveolar immune cells in patients with COVID-19. Nat. Med. 26, 842–844 (2020).

Article  CAS  Google Scholar 

Zuo, Y. et al. Autoantibodies stabilize neutrophil extracellular traps in COVID-19. JCI Insight 6, e150111 (2021).

Google Scholar 

Englert, H. et al. Defective NET clearance contributes to sustained FXII activation in COVID-19-associated pulmonary thrombo-inflammation. eBioMedicine 67, 103382 (2021).

Article  CAS  Google Scholar 

Semeraro, F. et al. Extracellular histones promote thrombin generation through platelet-dependent mechanisms: involvement of platelet TLR2 and TLR4. Blood 118, 1952–1961 (2011).

Article  CAS  Google Scholar 

Girard, P. et al. Deep venous thrombosis in patients with acute pulmonary embolism: prevalence, risk factors, and clinical significance. Chest 128, 1593–1600 (2005).

Article  Google Scholar 

Helms, J. et al. High risk of thrombosis in patients with severe SARS-CoV-2 infection: a multicenter prospective cohort study. Intensive Care Med. 46, 1089–1098 (2020).

Article  CAS  Google Scholar 

Chernysh, I. N. et al. The distinctive structure and composition of arterial and venous thrombi and pulmonary emboli. Sci. Rep. 10, 5112 (2020).

Article  CAS  Google Scholar 

Guan, W.-j et al. Clinical characteristics of coronavirus disease 2019 in China. N. Engl. J. Med. 382, 1708–1720 (2020).

Article  CAS  Google Scholar